
Allogeneic T Cell Therapies Global Market Report 2025
Description
Allogeneic T Cell Therapies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on allogeneic t cell therapies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for allogeneic t cell therapies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The allogeneic t cell therapies market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Product Type: Chimeric Antigen Receptor (CAR) T Cell Therapies; T Cell Receptor (TCR) Therapies; Other Product Types
2) By Antigen Type: CD 19; CD 20; Egfrvlll; GD2; CD22; CD30; CD33; Meso; HER1; Other Antigen Types
3) By Therapeutics Indications: Cancer; Autoimmune Diseases; Infectious Diseases; Others Therapeutics Indications
4) By End-User: Hospitals; Specialty Clinics; Research Institutes; Other End-Users
Subsegments:
1) By Chimeric Antigen Receptor (CAR) T Cell Therapies: CD19-targeted CAR T Therapies; BCMA-targeted CAR T Therapies; CD22-targeted CAR T Therapies
2) By T Cell Receptor (TCR) Therapies: Neoantigen-targeted TCR Therapies; Viral Antigen-targeted TCR Therapies
3) By Other Product Types: Engineered T Cell Therapies; NK Cell Therapies
Companies Mentioned: Bristol-Myers Squibb Company; Novartis AG; Gilead Sciences Inc.; Immatics NV; Sangamo Therapeutics Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on allogeneic t cell therapies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for allogeneic t cell therapies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The allogeneic t cell therapies market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Product Type: Chimeric Antigen Receptor (CAR) T Cell Therapies; T Cell Receptor (TCR) Therapies; Other Product Types
2) By Antigen Type: CD 19; CD 20; Egfrvlll; GD2; CD22; CD30; CD33; Meso; HER1; Other Antigen Types
3) By Therapeutics Indications: Cancer; Autoimmune Diseases; Infectious Diseases; Others Therapeutics Indications
4) By End-User: Hospitals; Specialty Clinics; Research Institutes; Other End-Users
Subsegments:
1) By Chimeric Antigen Receptor (CAR) T Cell Therapies: CD19-targeted CAR T Therapies; BCMA-targeted CAR T Therapies; CD22-targeted CAR T Therapies
2) By T Cell Receptor (TCR) Therapies: Neoantigen-targeted TCR Therapies; Viral Antigen-targeted TCR Therapies
3) By Other Product Types: Engineered T Cell Therapies; NK Cell Therapies
Companies Mentioned: Bristol-Myers Squibb Company; Novartis AG; Gilead Sciences Inc.; Immatics NV; Sangamo Therapeutics Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
200 Pages
- 1. Executive Summary
- 2. Allogeneic T Cell Therapies Market Characteristics
- 3. Allogeneic T Cell Therapies Market Trends And Strategies
- 4. Allogeneic T Cell Therapies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
- 5. Global Allogeneic T Cell Therapies Growth Analysis And Strategic Analysis Framework
- 5.1. Global Allogeneic T Cell Therapies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Allogeneic T Cell Therapies Market Growth Rate Analysis
- 5.4. Global Allogeneic T Cell Therapies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Allogeneic T Cell Therapies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Allogeneic T Cell Therapies Total Addressable Market (TAM)
- 6. Allogeneic T Cell Therapies Market Segmentation
- 6.1. Global Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chimeric Antigen Receptor (CAR) T Cell Therapies
- T Cell Receptor (TCR) Therapies
- Other Product Types
- 6.2. Global Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- CD 19
- CD 20
- Egfrvlll
- GD2
- CD22
- CD30
- CD33
- Meso
- HER1
- Other Antigen Types
- 6.3. Global Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cancer
- Autoimmune Diseases
- Infectious Diseases
- Others Therapeutics Indications
- 6.4. Global Allogeneic T Cell Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Specialty Clinics
- Research Institutes
- Other End-Users
- 6.5. Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of Chimeric Antigen Receptor (CAR) T Cell Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- CD19-targeted CAR T Therapies
- BCMA-targeted CAR T Therapies
- CD22-targeted CAR T Therapies
- 6.6. Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of T Cell Receptor (TCR) Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Neoantigen-targeted TCR Therapies
- Viral Antigen-targeted TCR Therapies
- 6.7. Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Engineered T Cell Therapies
- NK Cell Therapies
- 7. Allogeneic T Cell Therapies Market Regional And Country Analysis
- 7.1. Global Allogeneic T Cell Therapies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Allogeneic T Cell Therapies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Allogeneic T Cell Therapies Market
- 8.1. Asia-Pacific Allogeneic T Cell Therapies Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Allogeneic T Cell Therapies Market
- 9.1. China Allogeneic T Cell Therapies Market Overview
- 9.2. China Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Allogeneic T Cell Therapies Market
- 10.1. India Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Allogeneic T Cell Therapies Market
- 11.1. Japan Allogeneic T Cell Therapies Market Overview
- 11.2. Japan Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Allogeneic T Cell Therapies Market
- 12.1. Australia Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Allogeneic T Cell Therapies Market
- 13.1. Indonesia Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Allogeneic T Cell Therapies Market
- 14.1. South Korea Allogeneic T Cell Therapies Market Overview
- 14.2. South Korea Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Allogeneic T Cell Therapies Market
- 15.1. Western Europe Allogeneic T Cell Therapies Market Overview
- 15.2. Western Europe Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Allogeneic T Cell Therapies Market
- 16.1. UK Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Allogeneic T Cell Therapies Market
- 17.1. Germany Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Allogeneic T Cell Therapies Market
- 18.1. France Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Allogeneic T Cell Therapies Market
- 19.1. Italy Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Allogeneic T Cell Therapies Market
- 20.1. Spain Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Allogeneic T Cell Therapies Market
- 21.1. Eastern Europe Allogeneic T Cell Therapies Market Overview
- 21.2. Eastern Europe Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Allogeneic T Cell Therapies Market
- 22.1. Russia Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Allogeneic T Cell Therapies Market
- 23.1. North America Allogeneic T Cell Therapies Market Overview
- 23.2. North America Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Allogeneic T Cell Therapies Market
- 24.1. USA Allogeneic T Cell Therapies Market Overview
- 24.2. USA Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Allogeneic T Cell Therapies Market
- 25.1. Canada Allogeneic T Cell Therapies Market Overview
- 25.2. Canada Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Allogeneic T Cell Therapies Market
- 26.1. South America Allogeneic T Cell Therapies Market Overview
- 26.2. South America Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Allogeneic T Cell Therapies Market
- 27.1. Brazil Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Allogeneic T Cell Therapies Market
- 28.1. Middle East Allogeneic T Cell Therapies Market Overview
- 28.2. Middle East Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Allogeneic T Cell Therapies Market
- 29.1. Africa Allogeneic T Cell Therapies Market Overview
- 29.2. Africa Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Allogeneic T Cell Therapies Market Competitive Landscape And Company Profiles
- 30.1. Allogeneic T Cell Therapies Market Competitive Landscape
- 30.2. Allogeneic T Cell Therapies Market Company Profiles
- 30.2.1. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Immatics NV Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sangamo Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
- 31. Allogeneic T Cell Therapies Market Other Major And Innovative Companies
- 31.1. Poseida Therapeutics Inc.
- 31.2. Fate Therapeutics Inc.
- 31.3. Atara Biotherapeutics Inc.
- 31.4. Sorrento Therapeutics Inc
- 31.5. Autolus Therapeutics Plc
- 31.6. MaxCyte Inc.
- 31.7. Tessa Therapeutics Pte Ltd.
- 31.8. Cell Medica Inc.
- 31.9. Enlivex Therapeutics Ltd.
- 31.10. Cellectis SA
- 31.11. Adaptimmune Therapeutics Plc
- 31.12. Medigene AG
- 31.13. Celyad Oncology SA
- 31.14. Allogene Therapeutics Inc
- 31.15. Bellicum Pharmaceuticals Inc.
- 32. Global Allogeneic T Cell Therapies Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Allogeneic T Cell Therapies Market
- 34. Recent Developments In The Allogeneic T Cell Therapies Market
- 35. Allogeneic T Cell Therapies Market High Potential Countries, Segments and Strategies
- 35.1 Allogeneic T Cell Therapies Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Allogeneic T Cell Therapies Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Allogeneic T Cell Therapies Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.